i-SENS is pleased to announce its participation in the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD), one of the world’s leading congresses dedicated to diabetes research, treatment, and care.
EASD 2026 will take place from September 28 to October 2 at the Allianz MiCo – Milan Convention Centre in Milan, Italy, bringing together diabetes experts, healthcare professionals, and researchers from around the world.
At Booth #T.04, i-SENS will showcase its latest diabetes management solutions, with a particular focus on CareSens Air 2, its next-generation continuous glucose monitoring system scheduled for launch in early 2027. Featuring a smaller and lighter sensor, an extended wear period, and a newly redesigned app, CareSens Air 2 is designed to provide a more seamless and convenient CGM experience.
The booth will also feature Sens365, i-SENS’s integrated diabetes data management platform. By turning glucose data into clear, actionable insights, Sens365 supports healthcare professionals in making informed treatment decisions and delivering more personalized care.
Throughout the exhibition, i-SENS will host a series of in-booth presentations covering the development of CareSens Air 2, the integration of CareSens Air glucose data with Samsung Health insights, and education and support strategies for effective CGM implementation in real-world clinical practice.
A hands-on workshop for registered prescribers will also offer participants the opportunity to experience CareSens Air—from sensor application to app connectivity—and explore its practical use in clinical care.
By continuing to participate in leading international congresses such as EASD, i-SENS aims to engage with healthcare professionals worldwide, exchange valuable insights, and further strengthen its position as a trusted provider of comprehensive diabetes management solutions.